INCRELEX 10 mg/ml, solution injectable — 1 flacon(s) en verre de 4 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400938146776 -
CIP7
3814677 -
CIS
66263258 -
Registration number
EU/1/07/402
What the source publishes
- Holder
- ESTEVE PHARMACEUTICALS (ESPAGNE)
- Active ingredients
- MÉCASERMINE RECOMBINANTE
- Form
- solution injectable
- Package
- 1 flacon(s) en verre de 4 ml
- Routes
- sous-cutanée
- Administrative status
- authorised
- Supply regime
- prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ENDOCRINOLOGIE ; prescription réservée aux spécialistes et services MALADIES METABOLIQUES ; prescription hospitalière ; liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2007-08-03
- Prescription
- Prescription or restricted
Names this record is found by
- INCRELEX 10 mg/ml, solution injectable — 1 flacon(s) en verre de 4 ml
- INCRELEX 10 mg/ml, solution injectable
- MÉCASERMINE RECOMBINANTE
Complete source data
{
"cis": "66263258",
"cip7": "3814677",
"form": "solution injectable",
"name": "INCRELEX 10 mg/ml, solution injectable — 1 flacon(s) en verre de 4 ml",
"cip13": "3400938146776",
"holder": "ESTEVE PHARMACEUTICALS (ESPAGNE)",
"routes": [
"sous-cutanée"
],
"holders": [
"ESTEVE PHARMACEUTICALS (ESPAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "601.32",
"authorisedOn": "2007-08-03",
"compositions": [
{
"name": "MÉCASERMINE RECOMBINANTE",
"nature": "SA",
"strength": "10 mg",
"linkageNumber": "1",
"substanceCode": "77956",
"dosageReference": "1 ml",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ENDOCRINOLOGIE ; prescription réservée aux spécialistes et services MALADIES METABOLIQUES ; prescription hospitalière ; liste I",
"dispensingFee": "1.02",
"medicinePrice": "600.30",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "INCRELEX 10 mg/ml, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) en verre de 4 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100 %"
],
"marketingDeclaredOn": "2008-04-15",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"MÉCASERMINE RECOMBINANTE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription réservée aux spécialistes et services PEDIATRIE",
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ENDOCRINOLOGIE",
"prescription réservée aux spécialistes et services MALADIES METABOLIQUES",
"prescription hospitalière",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/07/402",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400938146776"